Prodromal dementia with Lewy bodies

@article{Donaghy2014ProdromalDW,
  title={Prodromal dementia with Lewy bodies},
  author={P. Donaghy and J. O'Brien and A. Thomas},
  journal={Psychological Medicine},
  year={2014},
  volume={45},
  pages={259 - 268}
}
Background The clinical condition of dementia is now recognized as a diagnosis that can only be applied too late in the disease process to be useful for therapeutic approaches centring on disease modification. As a result, in recent years increasing attention has been given to mild cognitive impairment (MCI) and the diagnosis of prodromal dementia. This paper reviews the evidence for the clinical presentation of prodromal dementia with Lewy bodies (DLB). Method A Medline search was carried out… Expand
The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias
TLDR
The findings of this systematic review indicate similar neuropsychological profiles in the MCI stages of DLB and PDD may at least partially explain poor performance in other domains. Expand
Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias.
  • J. Fields
  • Medicine
  • Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
  • 2017
TLDR
This review will focus on the cognitive and neuropsychiatric features of Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), with emphasis on neuropsychological findings. Expand
Detecting the Cognitive Prodrome of Dementia with Lewy Bodies: A Prospective Study of REM Sleep Behavior Disorder
TLDR
This study shows that cognitive tests assessing attention and executive functions strongly predict conversion to dementia in RBD patients, and may be useful endpoints to determine the effectiveness of interventions to prevent cognitive deterioration in R BD patients. Expand
Behavioral symptomatology and psychopharmacology of Lewy body dementia.
TLDR
The focus of this chapter is to discuss current LBD classification systems and assessments, neuropathology of LBDs, behavioral symptomatology, contemporary management options, and possible future targets of treatment. Expand
Exploring the Phenotype in Mild Cognitive Impairment to Aid the Prediction of Those at Risk of Transitioning to Parkinson Disease and Dementia With Lewy Bodies
TLDR
It is suggested that targeting nonamnestic MCI patients who report RBD with additional biomarker testing including smell, color vision, and neuroimaging may aid in early diagnosis and prediction of these α-synucleinopathies. Expand
Neuropsychiatric profiles in mild cognitive impairment with Lewy bodies.
TLDR
The NPI is a useful tool to detect NPS in those with MCI-LB, which had a higher prevalence of core features (visual hallucinations and RBD) and a higher LBNSSC than theMCI-AD group. Expand
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
TLDR
Early coexistence of autonomic and cognitive dysfunction in the setting of overt or latent parkinsonism as pitfalls in the differential diagnosis of α-synucleinopathies is focused on. Expand
Diagnosis of Lewy Body Dementia at the Prodromal Stage
This article addresses questions in the diagnosis of Lewy body dementia at the prodromal stage. Despite clinical studies using standard international criteria, cases of divergence between clinicalExpand
Lewy Body Spectrum Disorders: from Dementia with Lewy Bodies to Parkinson’s Disease Dementia
TLDR
Recent advances in the study of Lewy body disorders are discussed and how to apply them to clinical practice are discussed. Expand
Cerebrospinal Fluid, Imaging, and Physiological Biomarkers in Dementia With Lewy Bodies
TLDR
The neurophysiological, imaging, and CSF biomarkers in dementia with Lewy bodies are described and questioned whether they could be reliable tools for the clinical practice. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 57 REFERENCES
Diagnosis and management of dementia with Lewy bodies
TLDR
The authors propose a new scheme for the pathologic assessment of LBs and Lewy neurites (LN) using alpha-synuclein immunohistochemistry and semiquantitative grading of lesion density, with the pattern of regional involvement being more important than total LB count. Expand
Retrospective Survey of Prodromal Symptoms in Dementia with Lewy Bodies: Comparison with Alzheimer’s Disease
TLDR
Paying attention to non-motor symptoms of PD may help DLB diagnosis in the early stage, especially in terms of its differentiation from AD. Expand
Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease
TLDR
The data demonstrate the feasibility of differentiating underlying pathologic processes responsible for cognitive decline in the preclinical disease state and suggest that further refinement in diagnostic criteria may allow more accurate early detection of prodromal DLB and AD. Expand
Dementia with Lewy bodies: early diagnostic challenges
TLDR
A conceptual framework is proposed to identify these symptomatic but non‐demented individuals that led to suspect the underlying pathophysiology of Lewy body disease and further prospective study is warranted to determine the clinical significance of LB‐related symptoms in non‐Demented patients. Expand
Early and Presenting Symptoms of Dementia with Lewy Bodies
TLDR
DLB should be suspected in predementia cases with visual hallucinations, especially in patients with mild dementia fulfilling diagnostic criteria for DLB and Alzheimer’s disease. Expand
Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers
  • A. Tröster
  • Psychology, Medicine
  • Neuropsychology Review
  • 2008
TLDR
Although heterogeneous cognitive changes may manifest earlier and more frequently than previously appreciated in Parkinson’s disease (PD), and executive deficits may be harbingers of dementia, the enthusiasm to uncritically extend the concept of mild cognitive impairment (MCI) to PD should be tempered. Expand
Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies
TLDR
Inclusion of RBD as a core clinical feature improves the diagnostic accuracy of autopsy-confirmed DLB. Expand
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
TLDR
It could be more appropriate, for a consensus statement, to conclude that finding EEG abnormalities does not exclude the diagnosis of LBD, instead of asserting that EEG abnormalities support LBD diagnosis. Expand
Mild cognitive impairment as a diagnostic entity
TLDR
It is suggested that the diagnosis of mild cognitive impairment can be made in a fashion similar to the clinical diagnoses of dementia and AD, and an algorithm is presented to assist the clinician in identifying subjects and subclassifying them into the various types of MCI. Expand
Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.
TLDR
Loss of ChAT activity is less severe and occurs later in the clinical course of AD, suggesting that cholinergic replacement therapy may be more effective in LBV than in AD, especially in mild-stage disease. Expand
...
1
2
3
4
5
...